TNF‐α, as well as IL‐1β, induced keratinocyte activation plays a pivotal role in the pathogenesis of many inflammatory skin diseases, such as psoriasis, and different inhibitors of these cytokines have been proven to be a promising treatment in such diseases.22 This evidence concerns the gene IL1B and psoriasis.